Croda opens technical centre in Hyderabad
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Convergent action on AMR identified as an important area of intervention
Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient
The slogan for this year's World Blood Donor Day campaign is 'Give blood, give plasma, share life, share often'
Pfizer is likely to show GSK significant competition
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
UTD2 is the world's first oral epothilone microtubule inhibitor
Application being reviewed under the FDA Project Orbis framework, which enables concurrent reviews among US, Australia, Canada, Switzerland, Singapore and United Kingdom health authorities
The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement
Subscribe To Our Newsletter & Stay Updated